Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NIH alternative cancer therapy evaluation projects would originate in operations center.

This article was originally published in The Tan Sheet

Executive Summary

ALTERNATIVE CANCER THERAPY EVALUATION PROJECTS at NIH's Office of Alternative Medicine would originate at the OAM operations center under a proposed program from the National Institutes of Health. The Practice Outcomes Monitoring and Evaluation System (POMES) plan was presented by OAM and the National Cancer Institute at a meeting in Bethesda, Md. Aug. 4-6. Alternative cancer therapy studies to date mostly have focused on vitamin A and beta carotene.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087431

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel